3 Top Growth Stocks to Buy and Hold for 2025 скачать в хорошем качестве

3 Top Growth Stocks to Buy and Hold for 2025

The long-term outlooks for these high-quality companies are solid—and their stocks are cheap. 00:00 Introduction 00:36 Rentokil Initial RTO 01:13 Taiwan Semiconductor Manufacturing TSM 01:50 Coloplast CLPBY Susan Dziubinski: Hi. I’m Susan Dziubinski with Morningstar. Growth stocks looked about 24% overvalued coming into 2025, according to Morningstar. But that doesn’t mean that all growth stocks are overpriced these days. In fact, today we’re looking at three undervalued growth stocks that look attractive as long-term investments. All three companies are taken from Morningstar’s Best Companies to Own list. Our Best Companies to Own list features companies with significant competitive advantages—or what we call wide economic moats. These companies also have predictable cash flows and are well positioned to endure economic uncertainty. The first stock on our list of top growth stocks to buy and hold for 2025 is Rentokil Initial RTO. Rentokil is the world’s largest commercial pest-control business, holding leading market shares in most of the countries in which it operates. We expect global trends of increasing urbanization and growing economic prosperity to drive increased spending on Rentokil’s pest-control and other services. And we expect those trends to lead to solid organic revenue growth for the company over the coming decade. We think the stock is worth $40.30 and shares trade well below that. The second name on our list of top growth stocks to buy and hold in 2025 is Taiwan Semiconductor Manufacturing TSM. Taiwan Semi is the world’s largest dedicated chip foundry. Management recently issued upbeat guidance for 2025 and beyond, expecting AI chip revenue to balloon from 15% of overall revenue in 2024 to 50% of total revenue by 2029. Although Taiwan Semi’s stock was up more than 90% in 2024, shares still look undervalued: We think the stock is worth $273 per share. The final top growth stock to buy and hold in 2025 is Coloplast CLPBY. Coloplast is a leading global competitor in ostomy management and continence care. And Morningstar thinks that the company’s long record of meaningful innovation has allowed it to carve out a wide economic moat. The aging populations in developed countries and the growing incidence of inflammatory bowel disease should lead to growing demand for the company’s products. We expect Coloplast to achieve 8% revenue growth annually through fiscal 2028. Morningstar thinks Coloplast stock is worth $14.10 per share. What to watch from Morningstar. 3 Top Blue-Chip Stocks to Buy and Hold for 2025    • 3 Top Blue-Chip Stocks to Buy and Hold for...   Warren Buffett Bought These 3 Stocks. Only 2 of Them Are Buys Today    • Warren Buffett Bought These 3 Stocks. Only...   2 Cheap Dividend Aristocrats to Buy for 2025    • 2 Cheap Dividend Aristocrats to Buy for 2025   2 Stocks Top Global Fund Managers Have Been Buying    • 2 Stocks Top Global Fund Managers Have Bee...   Read what our team is writing. Susan Dziubinski: https://www.morningstar.com/people/su... Follow us on social. Facebook:   / morningstarinc   X: https://x.com/MorningstarInc Instagram:   / morningstar.  . LinkedIn:   / 5161